Stratification of Anatomical Imaging Features Between High-Risk and Non-High-Risk Groups in Neuroblastoma

被引:0
作者
Wang, Haoru [1 ]
Chen, Xin [1 ]
He, Ling [1 ]
Cai, Jinhua [1 ]
机构
[1] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Dept Radiol,Childrens Hosp,Chongqing Key Lab Child, Minist Educ Key Lab Child Dev & Disorders, 136 Zhongshan Rd 2, Chongqing 400014, Peoples R China
关键词
children; computed tomography; image-defined risk factors; magnetic resonance imaging; neuroblastoma; CLASSIFICATION-SYSTEM; SINGLE;
D O I
10.1177/10732748251315883
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study compared anatomical imaging features between high-risk and non-high-risk groups in neuroblastoma with at least one image-defined risk factor (IDRF). It also assessed the diagnostic performance of these features in identifying the high-risk group. Methods: A retrospective analysis of neuroblastoma patients with at least one IDRF was conducted. Imaging features, including estimated tumor volume and IDRFs, were compared between the two groups. The diagnostic performance of these features was assessed using receiver operating characteristic (ROC) curves, and the areas under the ROC curves (AUCs) along with their 95% confidence intervals (CIs) were calculated. Additionally, to internally validate their diagnostic performance, the bootstrap resampling method with 1000 bootstrap resamples was employed. Results: The study included 255 patients (185 high-risk cases, 70 non-high-risk cases). Significant differences were found in estimated tumor volume and IDRF number between the high-risk and non-high-risk groups (P < 0.001). The estimated tumor volume and the IDRF number-based cluster were independent risk factors, and their combination achieved an AUC of 0.801 (95% CI: 0.747-0.848) for high-risk group diagnosis, with the average AUC of the 1000 bootstrap samples of 0.800 (95% CI: 0.798-0.802). In abdominal lesions, specific IDRF categories differed between high-risk and non-high-risk groups (P < 0.05). Conclusion: Our study reveals anatomical imaging differences between high-risk and non-high-risk groups in neuroblastoma with at least one IDRF.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Molecular profiling of high-risk neuroblastoma by cDNA array
    Sardi, I
    Tintori, V
    Marchi, C
    Veltroni, M
    Lippi, A
    Tucci, F
    Tamburini, A
    Bernini, G
    Faulkner, L
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2002, 9 (05) : 541 - 545
  • [42] Intraoperative radiation therapy for high-risk pediatric neuroblastoma
    Haas-Kogan, DA
    Fisch, BM
    Wara, WM
    Swift, PS
    Farmer, DL
    Harrison, MR
    Albanese, C
    Weinberg, V
    Matthay, KK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04): : 985 - 992
  • [43] Value of surgical resection in children with high-risk neuroblastoma
    Englum, Brian R.
    Rialon, Kristy L.
    Speicher, Paul J.
    Gulack, Brian
    Driscoll, Timothy A.
    Kreissman, Susan G.
    Rice, Henry E.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (09) : 1529 - 1535
  • [44] Ototoxicity: a worrying problem for survivors of high-risk neuroblastoma
    Castel, Victoria
    Berlanga, Pablo
    TRANSLATIONAL CANCER RESEARCH, 2014, 3 (06) : 521 - 524
  • [45] Rapid COJEC versus standard induction therapies for high-risk neuroblastoma
    Peinemann, Frank
    Tushabe, Doreen A.
    van Dalen, Elvira C.
    Berthold, Frank
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (05):
  • [46] EXCELLENT LOCAL CONTROL FROM RADIATION THERAPY FOR HIGH-RISK NEUROBLASTOMA
    Gatcombe, Heather G.
    Marcus, R. B., Jr.
    Katzenstein, Howard M.
    Tighiouart, Mourad
    Esiashvili, Natia
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (05): : 1549 - 1554
  • [47] Ovarian function in female survivors of high-risk neuroblastoma
    Jimenez-Kurlander, Lauren
    DeRosa, Amelia
    Kostrzewa, Caroline E.
    Moskowitz, Chaya S.
    Bogardus, Kimberly
    Antal, Zoltan
    Wolden, Suzanne
    La Quaglia, Michael P.
    Basu, Ellen M.
    Cardenas, Fiorella Iglesias
    Kramer, Kim
    Kushner, Brian H.
    Cheung, Nai-Kong V.
    Modak, Shakeel
    Friedman, Danielle Novetsky
    PEDIATRIC BLOOD & CANCER, 2024, 71 (09)
  • [48] Evidence for the efficacy of immunotherapy in children with high-risk neuroblastoma
    Szychot, Elwira
    Peregud-Pogorzelski, Jaroslaw
    Wawrykow, Pawel
    Brodkiewicz, Andrzej
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2016, 70 : 1001 - 1004
  • [49] The importance of local control management in high-risk neuroblastoma in South Africa
    van Heerden, Jaques
    Kruger, Mariana
    Esterhuizen, Tonya
    Hendricks, Marc
    Geel, Jennifer
    Buchner, Ane
    Naidu, Gita
    du Plessis, Jan
    Vanemmenes, Barry
    Uys, Ronelle
    Hadley, G. P.
    PEDIATRIC SURGERY INTERNATIONAL, 2020, 36 (04) : 457 - 469
  • [50] MELK is a novel therapeutic target in high-risk neuroblastoma
    Guan, Shan
    Lu, Jiaxiong
    Zhao, Yanling
    Yu, Yang
    Li, Hui
    Chen, Zhenghu
    Shi, Zhongcheng
    Liang, Haoqian
    Wang, Mopei
    Guo, Kevin
    Chen, Xiangmei
    Sun, Wenjing
    Bieerkehazhi, Shayahati
    Xu, Xin
    Sun, Surong
    Agarwal, Saurabh
    Yang, Jianhua
    ONCOTARGET, 2018, 9 (02) : 2591 - 2602